Clinicopathological Role of Serum-Derived Hyaluronan-Associated Protein (SHAP)-Hyaluronan Complex in Endometrial Cancer

Table 5

Correlationship between the serum HA, SHAP-HA complex, MMP-2, MMP-9, TIMP-1, and UTI in patients with endometrial cancer.

Variables	𝑟	𝑃 value
HA and SHAP-HA complex	0.466	0.0005
HA and UTI	0.306	0.0305
HA and MMP-2	0.007	0.9635
HA and MMP-9	0.345	0.0137
HA and TIPM-1	0.364	0.0089
SHAP-HA complex and UTI	0.235	0.1004
SHAP-HA complex and MMP-2	0.066	0.6523
SHAP-HA complex and MMP-9	0.455	0.0008
SHAP-HA complex and TIMP-1	0.396	0.0041
UTI and MMP-2	−0.061	0.6739
UTI and MMP-9	0.071	0.6242
UTI and TIMP-1	0.255	0.0736
MMP-2 and MMP-9	0.032	0.827
MMP-2 and TIMP-1	0.386	0.0053
MMP-9 and TIMP-1	0.677	<0.0001